Open AccessFertility Preservation in Leukemia
Author(s) -
Blumenfeld Zeev
Publication year - 2018
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2017-0635
Subject(s) - medicine , fertility preservation , myeloid leukemia , fertility , tyrosine kinase , oncology , stem cell , hematopoietic stem cell transplantation , transplantation , leukemia , haematopoiesis , cancer research , immunology , population , receptor , environmental health , biology , genetics
This article comments on the study by Gazdaru et al., who report a case of chronic myeloid leukemia resistant to tyrosine kinase inhibitors (TKIs). Treatment by TKI was replaced by interferon‐α (INF‐α), and the patient underwent hematopoietic stem cell transplantation, resulting in successful ovarian stimulation for fertility preservation.